Questions discussed in this category
For example, in patients who are HbSAg negative, anti-HBc positive and HbSAb negative, does vaccination reduce reactivation risk?
Such as patients with negative Hepatitis B surface antigen and negative viral load but with positive hepatitis b core antibody.
If so, for what platelet count threshold and do you have a preference as to which agent?
Is there a "best" way to approach treatment of the viral infection i.e concurrently with therapy, prior to therapy, delayed or post therapy? Does this...
22874222902077219962200101850418458174351436963076068
Papers discussed in this category
J. Hepatol., 2019 Apr 06
Gastroenterology, 2018 May 17
Clin. Gastroenterol. Hepatol., 2018 Nov 28
Hepatology (Baltimore, Md.), 2019-10
The New England journal of medicine, 1987-03-05
Hepatology (Baltimore, Md.), 2018 Apr
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020 Dec 31
Journal of viral hepatitis, 2019 Dec 22
Topics in antiviral medicine, 2023 Mar 31
Journal of acquired immune deficiency syndromes (1999), 2023 Oct 01
Lancet (London, England), 2013-02-09
Clinics in liver disease, 2023 Jul 27
Am J Gastroenterol, 2023 Sep 1
The oncologist, 2021 Mar 20
Medicine, 2020 Jan